Clinical Trial Update: Stereotactic Body Radiation With Nelfinavir for Oligometastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic body radiotherapy with nelfinavir for oligometastases has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligometastases

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Oligometastases | Phase 2 | Status: COMPLETED | Results posted: 2021-04-23